Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn's Disease Patients Rational and Feasible? Data from a Feasibility Test.
Hoelz H, Heetmeyer J, Tsakmaklis A, Hiergeist A, Siebert K, De Zen F, Häcker D, Metwaly A, Neuhaus K, Gessner A, Vehreschild MJGT, Haller D, Schwerd T. Hoelz H, et al. Among authors: tsakmaklis a. Nutrients. 2023 Apr 2;15(7):1742. doi: 10.3390/nu15071742. Nutrients. 2023. PMID: 37049583 Free PMC article.
Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection.
Farowski F, Solbach P, Tsakmaklis A, Brodesser S, Cruz Aguilar MR, Cornely OA, Dettmer K, Higgins PG, Suerbaum S, Jazmati N, Oefner PJ, Vehreschild MJGT; German Clinical Microbiome Study Group (GCMSG). Farowski F, et al. Among authors: tsakmaklis a. Dig Liver Dis. 2019 Jul;51(7):944-951. doi: 10.1016/j.dld.2019.01.012. Epub 2019 Jan 26. Dig Liver Dis. 2019. PMID: 30770201
Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR).
Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, Schafhausen P, Rohde H, von Lilienfeld-Toal M, Klassert TE, Slickers P, Ehricht R, Slevogt H, Christ H, Hellmich M, Farowski F, Tsakmaklis A, Higgins PG, Seifert H, Vehreschild MJGT. Dimitriou V, et al. Among authors: tsakmaklis a. J Antimicrob Chemother. 2019 Jul 1;74(7):2065-2074. doi: 10.1093/jac/dkz124. J Antimicrob Chemother. 2019. PMID: 31220256 Clinical Trial.
Biomarkers of human gut microbiota diversity and dysbiosis.
Rüb AM, Tsakmaklis A, Gräfe SK, Simon MC, Vehreschild MJ, Wuethrich I. Rüb AM, et al. Among authors: tsakmaklis a. Biomark Med. 2021 Feb;15(2):137-148. doi: 10.2217/bmm-2020-0353. Epub 2021 Jan 14. Biomark Med. 2021. PMID: 33442994
Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study.
Biehl LM, Farowski F, Hilpert C, Nowag A, Kretzschmar A, Jazmati N, Tsakmaklis A, Wieters I, Khodamoradi Y, Wisplinghoff H, Vehreschild MJGT. Biehl LM, et al. Among authors: tsakmaklis a. PLoS One. 2022 Jan 14;17(1):e0262095. doi: 10.1371/journal.pone.0262095. eCollection 2022. PLoS One. 2022. PMID: 35030190 Free PMC article.
12 results